ERBB3 and neoplasm: Yosef Yarden’ lab generated mouse mAbs against the ECD of HER3 [179] that accelerate HER3 degradation and inhibit growth in vitro and in tumor-bearing animals, specially NG33 alone or in combination with other anti-HER3 Abs.